01/27/12 - 4:15 pm

Bionovo to Voluntarily Delist from NASDAQ

01/05/12 - 8:00 am

Robert Farrell Joins Bionovo's Board of Directors

01/04/12 - 8:00 am

Bionovo Appoints New Senior Vice President and Chief Financial Officer

01/03/12 - 8:00 am

Bionovo Announces $5 Million Financing

12/08/11 - 8:00 am

Bionovo Announces the Publication of its Tissue Selective Estrogen Receptor Modulators for Postmenopausal Obesity

11/16/11 - 12:22 pm

Bionovo Announces "First Patient, First Dose" in Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes

11/10/11 - 4:01 pm

Bionovo Announces Third Quarter 2011 Highlights and Financial Results

10/26/11 - 4:38 pm

Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes

09/20/11 - 8:00 am

Bionovo to Present Tissue Selective Estrogen Receptor Modulators for Obesity at the 22nd Annual Meeting of the North American Menopause Society

09/19/11 - 8:00 am

Bionovo Announces an Additional 180 Day Period to Regain Compliance With Nasdaq's Bid Price Rule

08/30/11 - 8:00 am

Bionovo Announces Positive Results of the Tolerability Trial of Menerba (MF101) for Menopausal Hot Flashes

08/29/11 - 8:00 am

Bionovo to Host a Conference Call to Discuss Menerba's Tolerability Trial Results

08/05/11 - 8:00 pm

CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results

08/03/11 - 8:00 am

Bionovo Announces Second Quarter 2011 Highlights and Financial Results

07/25/11 - 8:00 am

Bionovo Announces Successful Completion of Animal Toxicology Studies for MF101 (Menerba™)

07/18/11 - 8:00 am

Bionovo Announces Publication of Bezielle™ Effect on Metabolic Fluxes in Breast Cancer

06/07/11 - 8:00 am

Bionovo to Present Novel Approaches to Analytical Chemistry of Botanical Mixtures

06/02/11 - 8:00 am

Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause

05/11/11 - 4:05 pm

Bionovo Announces First Quarter 2011 Highlights and Financial Results

05/06/11 - 3:01 pm

Bionovo to Announce First Quarter Financial Results on Wednesday, May 11, 2011

03/28/11 - 8:05 am

Bionovo Announces Enrollment Started in the Menerba (MF101) Phase 1 "Tolerability" Clinical Trial for Menopausal Hot Flushes

03/15/11 - 4:30 pm

Bionovo Announces 2010 Highlights and Year-End Financial Results

03/14/11 - 8:00 am

Bionovo, Inc. to Announce Fourth Quarter Fiscal Year 2010 Financial Results on Tuesday, March 15, 2011

03/07/11 - 8:00 am

Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference

02/10/11 - 5:10 pm

Bionovo Announces 2011 Plan of Action on MF101 (Menerba(TM))

02/02/11 - 4:02 pm

Bionovo Announces Closing of Follow-on Offering of Common Stock and Warrants

01/28/11 - 9:12 am

Bionovo Announces Pricing of Follow-on Offering of Common Stock and Warrants

12/15/10 - 8:00 am

Bionovo Announces Publication Describing How Metabolic Adaptability Contributes to the Metastasis of Tumors

12/13/10 - 8:00 am

Bionovo Releases FDA-Approved Clinical Development Plan for Menerba

12/08/10 - 4:01 pm

Bionovo Announces Publication Describing Estrogen Receptor Beta Cancer Prevention Mechanism

11/15/10 - 8:00 am

Bionovo, Inc. to Present at the Maxim Group Growth Conference

11/11/10 - 4:01 pm

Bionovo Announces Third Quarter 2010 Highlights and Financial Results

11/10/10 - 8:00 am

FDA Approves Bionovo's Clinical Development Plan for Menerba

11/04/10 - 8:00 am

Bionovo, Inc. to Announce Third Quarter Fiscal Year 2010 Financial Results on Thursday, November 11, 2010

11/02/10 - 8:00 am

Bionovo Receives QTDP Grant from Federal Government

10/25/10 - 8:00 am

Bionovo Comments on Recent Hormone Therapy (HT) Risk Disclosures

10/21/10 - 4:01 pm

Bionovo Announces Publication Describing Potential Estrogen Receptor Modulating Drugs for Treating Menopausal Conditions

10/01/10 - 3:10 pm

Bionovo to Raise $3 Million Through Registered Direct Offering

09/23/10 - 8:00 am

FDA Approves Manufacturing Plan for Menerba, Bionovo's Menopausal Hot Flash Drug Candidate

09/21/10 - 8:00 am

Bionovo to Present at the JMP Securities Healthcare Conference

09/16/10 - 8:00 am

Bionovo Regains Compliance With NASDAQ Minimum Closing Bid Price Requirement

09/13/10 - 4:01 pm

Bionovo to Present at Cambria Capital Investor Meeting

09/02/10 - 8:00 am

Bionovo Receives NIH Grant to Develop Drugs for the Treatment of Female-Specific Obesity and Metabolic Syndrome

08/30/10 - 7:25 pm

Bionovo Receives Positive Guidance from FDA on Menerba®

08/30/10 - 6:00 pm

Bionovo Announces Reverse Stock Split

08/12/10 - 8:00 am

Bionovo to Present at the Southern California Investor Conference

08/11/10 - 8:00 am

Bionovo Adds Dr. James H. Pickar, Former Executive at Wyeth, to Medical Advisory Board

08/10/10 - 8:00 am

LifeTech Capital Initiates Coverage of Bionovo

08/04/10 - 4:01 pm

Bionovo Announces Second Quarter 2010 Highlights and Financial Results

08/02/10 - 8:00 am

Bionovo Announces Publication Describing Menerba's Effect on Neural Pathways Related to Temperature Regulation

07/29/10 - 5:00 am

Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe

07/28/10 - 9:00 am

Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010

07/06/10 - 7:00 pm

Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement

06/11/10 - 7:00 am

Bionovo Announces Publication Describing the Discovery of Distinct Classes of Genes Regulated By Estrogen Receptor Beta

05/27/10 - 7:01 am

Dr. Richard Weiner, Ph.D., Joins Bionovo Scientific Advisory Board

05/25/10 - 7:02 am

Bionovo Develops a High Throughput LC-MS/MS Tandem Quantification of Multiple Bioactive Compounds

05/11/10 - 4:04 pm

Bionovo Announces First Quarter 2010 Highlights and Financial Results

05/04/10 - 4:03 pm

Bionovo, Inc. to Announce First Quarter Fiscal Year 2010 Financial Results on Tuesday, May 11, 2010

04/28/10 - 3:31 pm

Bionovo to Hold Annual Shareholder Meeting May 3, 2010

04/20/10 - 6:45 pm

Bionovo Announces Patent Issuance for Bezielle(R) (BZL101) for Metastatic Breast Cancer

03/18/10 - 11:14 pm

Bionovo Notified by NASDAQ of Extension

03/15/10 - 4:04 pm

Bionovo Announces 2009 Highlights and Year-End Financial Results

03/08/10 - 4:04 pm

Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010

02/10/10 - 8:05 am

Dr. Paul Pui-Hay But, Ph.D. Joins Bionovo, Inc. Scientific Advisory Board

01/14/10 - 8:06 am

Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer

01/06/10 - 8:08 am

Dr. Marco Gambacciani, M.D. Joins Bionovo, Inc. Medical Advisory Board

12/29/09 - 8:03 am

Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer

11/05/09 - 4:04 pm

Bionovo Announces Third Quarter 2009 Highlights and Financial Results

11/05/09 - 8:07 am

Steven R. Goldstein, M.D., Joins Bionovo's Menerba Medical Advisory Board

10/29/09 - 8:05 am

Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009

10/20/09 - 8:06 am

Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta

10/14/09 - 6:01 am

Bionovo Adds Dr. Debu Tripathy to Their Medical Advisory Board

10/02/09 - 9:26 am

Bionovo Announces Pricing of Securities Offering

10/01/09 - 11:18 am

Bionovo Announces Publication Describing the Selective Anti-tumor Activity of its Drug Candidate BN108

09/25/09 - 8:02 am

Bionovo to Present at the Maxim Group Growth Conference

09/24/09 - 12:09 pm

Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society

09/21/09 - 4:06 pm

Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency

09/03/09 - 8:04 am

Bionovo to Present Positive Results from Phase 2 Trial of Menerba for Vasomotor Symptoms to the International Community

08/10/09 - 3:01 pm

Bionovo Announces Second Quarter 2009 Highlights and Financial Results

08/04/09 - 7:32 am

Bionovo Presents Positive Results from Phase 1B Trial of Bezielle for Metastatic Breast Cancer

08/03/09 - 4:17 pm

Bionovo, Inc. to Announce Second Quarter Fiscal Year 2009 Financial Results on Monday, August 10, 2009

07/29/09 - 9:04 am

Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference

07/17/09 - 8:02 am

Bionovo's Estrogen Receptor Beta Selective Drugs Have Unique Gene Expression and Cell Type Specificity

06/11/09 - 4:31 pm

Bionovo Announces Arbitration Decision in Lawsuit Filed by Former Officer - All Claims Denied

06/02/09 - 8:06 am

Bionovo Appoints Dr. Klaus Kohl as Chief Technical Officer

05/07/09 - 4:08 pm

Bionovo Announces First Quarter 2009 Highlights and Financial Results

04/30/09 - 9:03 am

Bionovo, Inc. to Announce First Quarter Fiscal Year 2009 Financial Results on Thursday, May 7, 2009

04/20/09 - 9:05 am

Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108

04/03/09 - 7:22 pm

Bionovo to Present at the Cambria Capital Investor Meeting

03/18/09 - 5:01 pm

Bionovo to Present at Wall Street Analyst Forum's 20th Annual Institutional Investor Conference

03/12/09 - 4:16 pm

Bionovo Announces 2008 Highlights and Year-End Financial Results

03/06/09 - 1:20 pm

Bionovo, Inc. to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 12, 2009

03/02/09 - 8:05 am

Bionovo Announces Publication of Positive Phase 2 Trial Results for Menerba(TM)

02/17/09 - 8:07 am

Bert W. O'Malley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovo's Scientific Advisory Board

02/09/09 - 8:06 am

Jan Ake Gustafsson, M.D., Ph.D., Joins Bionovo's Scientific Advisory Board

02/04/09 - 1:06 pm

Bionovo Announces Presentation at the National Cancer Institute

01/15/09 - 8:03 am

Bionovo Announces Cost Control Measures Taken

01/02/09 - 6:04 pm

Bionovo Publishes Discoveries in Predictable Tissue Selectivity for Selective Estrogen Receptor Modulators Platform

12/15/08 - 3:02 pm

Willa A. Hsueh, M.D., Joins Bionovo's Scientific Advisory Board

12/12/08 - 8:03 am

Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium

12/12/08 - 8:02 am

Bionovo to Present Recent Findings of BN107, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium

12/03/08 - 7:02 am

Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings

12/02/08 - 10:40 am

Bionovo to Present at the Piper Jaffray Healthcare Conference

11/20/08 - 1:34 pm

Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology

11/12/08 - 8:06 am

Ethan Weiss, M.D., Joins Bionovo's Scientific Advisory Board

11/11/08 - 8:07 am

Bionovo to Present at the Rodman & Renshaw 10th Annual Global Investment Conference

11/03/08 - 4:42 pm

Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer

11/03/08 - 4:40 pm

Bionovo Reports Third Quarter 2008 Financial Results